State Ceases Tests to Spot Methadone Misuse

The Associated Press State & Local Wire, May 3, 2005.

DATELINE: Baltimore

The state health department has stopped running laboratory tests for Maryland’s methadone clinics, removing a safeguard against misuse of the drug, potentially worsening what authorities say is a growing problem.

Methadone, a heroin replacement medication, is used by about 13,400 recovering addicts in Maryland. To start on the medication, addicts must go to one of the state’s 40 approved clinics. Federal law allows clients who have gone through months of daily visits without relapse can earn the opportunity to take home at least some doses.

For at least 20 years, clinics have had one reliable method of making sure take-home doses don’t end up being abused for a high by the clients or resold on the street: They have randomly called some clients and ordered them to return their doses within a day.

Because it’s difficult to tell whether the returned bottles holding the syruplike drug have been tampered with, clinics have sent them to a state lab to make sure they match the dosage given to clients. If the lab found a mismatch, as occurred in about 10 percent of the 4,000 samples it checked annually, the client lost his or her take-home privileges.

But last month, the Laboratories Administration of the Department of Health and Mental Hygiene notified clinics that, because of budget cuts, the state would no longer do the testing.

Clinic directors say the move will make it much harder to ensure that clients are using their take-home doses as directed.

The lab testing “is the only tool we have with which to determine that the people we’re giving the bottles to are making responsible use of their medication,” said Carol Butler, director of the Reach clinic, which serves 450 clients at a van parked in Baltimore’s Barclay neighborhood. “We take our jobs seriously, and we have no other way to enforce to make sure that the people we think are doing well really are.”

The move occurs at a time of growing concern about the risks of methadone abuse. Fatal overdoses involving methadone increased fivefold in the state between 1998 and last year, to 124, a rise attributed to the diversion of methadone from clinics and of methadone prescribed as pain medication.

“It’s penny-wise and pound-foolish. I don’t understand it,” said Frank Satterfield, director of Glenwood Life, in Baltimore’s Govans neighborhood.

Similar Posts

  • Tag: DOJ

    Admin 07/20/2021

    DOJ publishes guidance on Opioid Use Disorder and the Americans with Disabilities Act April 15, 2022 “The opioid crisis poses an extraordinary challenge to communities throughout our country. The Department of Justice (the Department) has responded with a comprehensive approach prioritizing prevention, enforcement, and treatment. This includes enforcing the Americans with Disabilities Act (Ada), which…

  • AMTA’S Five-Year Plan for Methadone Treatment In the United States

    Admin 05/30/2023

    AMTA’S Five-Year Plan for Methadone Treatment In the United States Presented at the Policy Makers Luncheon National Methadone Conference St. Louis, October 7-10, 2001 Accreditation (2001-2005) CSAT implemented new federal standards for accrediting methadone treatment programs on May 18, 2001. I submitted AMTA’s testimony in support of accreditation during my presentation to the Federal Interagency…

  • NOTE:

    Admin 08/18/2022

    The Federal Regulations Pages are a work in progress. In coming weeks they will be better formatted, indexed, etc. But due to overwhelming demand, we have decided to place them up AS IS for the time being. Please inform us of typos, etc. PS- New York State regulations coming soon! If you have the methadone…

  • The National Methadone Conference-3

    Admin 05/13/2023

    American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Session: Organizational Meeting April 15, 2003 Picture Essay of NAMA’s Organizational Meeting Starting the Meeting Joyce calls the meeting to order. Top (l-r) Robert Sanders (NYC NAMA), Becki Ballard (OK NAMA), Gary Nessenbaum (WAMM), Jennifer Nelson Connelly (PA NAMA), Joycelyn Woods,…

  • Category: AATOD

    Admin 12/26/2021

    Congratulations to Sara Gefvert, the 2022 Lane/Holden Award Winner! November 2, 2022 The 2022 Richard Lane/Robert Holden Patient Advocacy Award was presented at an Awards Reception held in conjunction with the 2022 Conference of the American Association for the Treatment of Opioid Dependence (AATOD) in Baltimore, Maryland on November 2, 2022. Richard Lane/Robert Holden Patient…

  • Complete Training

    Admin 08/05/2021

    Training for Certified Medication Assisted Treatment Advocate (CMA) National Alliance for Medication Assisted Recovery (NAMA Recovery) Complete Your Training You will need to mail in the CMA Test and Application to receive your certificate. If you have any questions contact: Walter Ginter Expired CMA’s Need to Recertify Pay for 2 Years of Membership and send…